Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Jul;18(1):208–209. doi: 10.1128/aac.18.1.208

Protection of staphylococci ingested by macrophages from the bactericidal action of rifampin.

E L Pesanti
PMCID: PMC283966  PMID: 7416746

Abstract

The ability of rifampin to kill Staphylococcus aureus which have been ingested by normal mouse peritoreal macrophages in vitro has been investigated. In contrast to data which have been reported from experiments with other cell types, in this system rifampin was no more active than was penicillin against the two strains tested.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J. W., Good R. A. Effect of antibiotics on the bactericidal activity of human leukocytes. J Lab Clin Med. 1968 Jun;71(6):971–983. [PubMed] [Google Scholar]
  2. Baughn R., Bonventre P. F. Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect Immun. 1975 Aug;12(2):346–352. doi: 10.1128/iai.12.2.346-352.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beam T. R., Jr Sequestration of staphylococci at an inaccessible focus. Lancet. 1979 Aug 4;2(8136):227–228. doi: 10.1016/s0140-6736(79)90239-3. [DOI] [PubMed] [Google Scholar]
  4. Clini V., Grassi C. The action of new antituberculous drugs on intracellular tubercle bacilli. Antibiot Chemother. 1970;16:20–26. doi: 10.1159/000386799. [DOI] [PubMed] [Google Scholar]
  5. Cole P., Brostoff J. Intracellular killing of Listeria monocytogenes by activated macrophages (Mackaness system) is due to antibiotic. Nature. 1975 Aug 7;256(5517):515–517. doi: 10.1038/256515a0. [DOI] [PubMed] [Google Scholar]
  6. Ezer G., Soothill J. F. Intracellular bactericidal effects of rifampicin in both normal and chronic ganulomatous disease polymorphs. Arch Dis Child. 1974 Jun;49(6):463–466. doi: 10.1136/adc.49.6.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lobo M. C., Mandell G. L. Treatment of experimental staphylococcal infection with rifampin. Antimicrob Agents Chemother. 1972 Sep;2(3):195–200. doi: 10.1128/aac.2.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mandell G. L., Vest T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis. 1972 May;125(5):486–490. doi: 10.1093/infdis/125.5.486. [DOI] [PubMed] [Google Scholar]
  9. McCabe W. R., Lorian V. Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci. 1968 Oct;256(4):255–265. doi: 10.1097/00000441-196810000-00007. [DOI] [PubMed] [Google Scholar]
  10. Nugent K. M., Pesanti E. L. Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages. Infect Immun. 1979 Nov;26(2):651–657. doi: 10.1128/iai.26.2.651-657.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Solberg C. O., Hellum K. B. Protection of phagocytosed bacteria against antimicrobial agents. Scand J Infect Dis Suppl. 1978;(14):246–250. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES